0
Seelos Therapeutics, Inc. Banner Image

Seelos Therapeutics, Inc. has reached its limit for free report views

Work for Seelos Therapeutics, Inc.? Upgrade Your Profile and unlock all your annual reports.

Seelos Therapeutics, Inc.

  • Ticker SEEL
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Seelos Therapeutics, Inc. Logo Image
  • 1-10 Employees
  • Based in New York City, New York
Seelos Therapeutics, Inc. is a clinical-stage bio-pharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system (CNS) disorders and in rare diseases. The Company’s portfolio includes several late-stage clinical assets targeting psychiatric and movement disorders, including orphanMore diseases. Seelos is based in New York, New York. Seelos’ common stock is traded on The Nasdaq Capital Market under the symbol "SEEL"​.
Seelos Therapeutics, Inc.

Most Recent Annual Report

Seelos Therapeutics, Inc. MOST RECENT 2020 Annual Report and Form 10K

Report Locked. Seelos Therapeutics, Inc. has reached its limit for free report views.

Older/Archived Annual Reports